NP

Niyoshi Patel

Director, Business Development & Investments at BeiGene

New York, New York

Overview 

Niyoshi Patel is currently the Director of Business Development & Investments at BeiGene in New York, specializing in biotechnology investments and entrepreneurial ventures. With a background in business planning and due diligence, Niyoshi has held key roles at reputable firms like SV Health Investors and Purdue Pharma, demonstrating expertise in financial modeling and market research within the pharmaceutical sector.

Work Experience 

  • Director, Business Development & Investments

    2023 - Current

  • Associate Director, Business Development & Investments

    2022 - 2023

BeiGene is a global oncology company.

Raised $6,790,000,000.00 from Hillhouse Investment, Amgen Ventures, GIC and Amgen.

  • Investment Associate (Dementia Discovery Fund)

    2020 - 2022

SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.

  • MBA Intern, Business Development

    2019 - 2019

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

Raised $3,436,600,000.00 from Hercules Capital.

  • Pre-MBA Intern, Strategy & Business Development

    2018 - 2018

    Acquired by Eli Lilly

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

Raised $129,000,000.00 from EcoR1 Capital, Alexandria Venture Investments, Adage Capital Management, OrbiMed, RA Capital Management, Biotechnology Value Fund, Pontifax, Omega Funds, Surveyor Capital and AbbVie.

  • Senior Manager, Business Development

    2016 - 2018

Purdue Pharma develops, manufactures, and markets medications and consumer health products.

Raised $1,800,000.00 from US Department of Energy.

  • Analyst

    2014 - 2016

    Directly assisted partners in all aspects of deal diligence (conducting market research, building financial models, creating investment committee presentations, evaluating management teams, finalizing legal documentation, etc.) Assisted deal teams on various business development initiatives for portfolio companies (identifying potential acquisition opportunities, analyzing market trends, etc.) Completed quarterly valuations of the fund’s portfolio

Athyrium Capital Management is a specialized asset management company focusing on investment opportunities in the global healthcare sector.

  • Analyst

    2012 - 2014

    Assisted in deal diligence, researched and developed investment theses on industry segments, and sourced various opportunities in attractive areas Worked with portfolio companies to develop and implement plans to improve overall profitability

The principals of Great Point Partners have a long history of helping executives build successful health care companies.

  • Private Equity Group, Summer Analyst

    2011 - 2011

Goldman Sachs is a multinational financial services firm providing securities, investment banking, and management services.

  • Co-Founder

    2008 - 2010

Articles About Niyoshi

Relevant Websites